Pear Therapeutics Inc. (PEARQ)
OTCMKTS: PEARQ · Delayed Price · USD
0.00
0.00 (0.00%)
Apr 30, 2024, 4:00 PM EDT - Market closed

Pear Therapeutics Revenue

In the year 2022, Pear Therapeutics had annual revenue of $12.69M with 201.66% growth. Revenue in the quarter ending December 31, 2022 was $2.57M with 94.32% year-over-year growth.

Revenue (ttm)
$12.69M
Revenue Growth
+201.66%
P/S Ratio
0.00
Revenue / Employee
$63,470
Employees
200
Market Cap
142.00 USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202212.69M8.49M201.66%
Dec 31, 20214.21M-5.18M-55.16%
Dec 31, 20209.38M-23.18M-71.18%
Dec 31, 201932.56M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.